【レポートの概要(一部)】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Pipeline portfolio
• Pipeline portfolio: Global diabetes drugs market
• Pipeline portfolio: Global hyperphosphatemia drugs market
• Pipeline portfolio: Global anti-obesity drugs market
PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 07: Market segmentation by type of disease
• Diabetes
• Obesity
• Hypercholesterolemia
• Lysosomal storage diseases
PART 08: Global diabetes drugs market
• Market overview
• Global type 1 diabetes market
• Global type 2 diabetes drugs market
• Vendors in global diabetes drugs market
PART 09: Global hypercholesterolemia drugs market
• Market overview
• Vendors in global hypercholesterolemia drugs market
PART 10: Global lysosomal storage diseases market
• Market overview
• Vendors in global lysosomal storage disorders drugs market
PART 11: Global anti-obesity drugs market
• Market overview
• Vendors in global anti-obesity drugs market
PART 12: Geographical segmentation
• Global metabolic disorders therapeutics market by geography 2015-2020
• Metabolic disorders therapeutics market in Americas
• Metabolic disorders therapeutics market in EMEA
• Metabolic disorders therapeutics market in APAC
PART 13: Market drivers
• Patient assistance programs
• Special regulatory designations for rare diseases
• Increase in academia-industry collaborations for drug development
PART 14: Impact of drivers
PART 15: Market challenges
• Low compliance and adherence rates
• High cost of therapies
• Complex storage conditions and distribution policies for insulin
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Focus on oral insulin therapies
• Strong and diversified pipeline portfolio
• Strategic collaborations and acquisitions
PART 18: Vendor landscape
• Competitive scenario
• Other prominent vendors
•
PART 19: Key vendor analysis
• Novo Nordisk
• Sanof
• Merck
• AstraZeneca
• Eli Lilly
PART 20: Appendix
• List of abbreviations
PART 21: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria and customer segments for metabolic disorder drugsKey buying criteria for metabolic disorders drugs 2015
Exhibit 03: Impact of key customer segments on market 2015
Exhibit 04: Global metabolic disorders therapeutic market snapshot: Developed and emerging markets 2015
Exhibit 05: Global metabolic disorders therapeutics market 2015-2020 ($ billions)
Exhibit 06: Opportunity analysis: Global metabolic disorders therapeutics market
Exhibit 07: Global metabolic disorders therapeutics market: Growth cycle analysis
Exhibit 08: Five forces analysis
Exhibit 09: Global metabolic disorders therapeutics market by type of disease
Exhibit 10: Global metabolic disorders therapeutics market by type (2015-2020)
Exhibit 11: Global metabolic disorders therapeutics market n growth lifecycle analysis
Exhibit 12: Top selling diabetes drugs based on sales 2015 ($ billions)
Exhibit 13: Market share of global diabetes drugs in global pharmaceutical market 2015
Exhibit 14: Global diabetes drugs market 2015-2020 ($ billions)
Exhibit 15: Global type 1 diabetes market 2015-2020 ($ billions)
Exhibit 16: Global type 2 diabetes drugs market 2015-2020 ($ billions)
Exhibit 17: Market share analysis of vendors in global diabetes drugs market
Exhibit 18: Revenues from the sales of top five products in global diabetes drugs market 2013-2015 ($ billions)
Exhibit 19: Revenues from the sales of top five products in hypercholesterolemia drugs market 2013-2015 ($ billions)
Exhibit 20: Market dynamics of hypercholesterolemia drugs
Exhibit 21: Percentage share of hypercholesterolemia drugs by drug class 2015
Exhibit 22: Global hypercholesterolemia drugs market 2015-2020 ($ billions)
Exhibit 23: Market share analysis of global hypercholesterolemia drugs market 2015
Exhibit 24: Products offered by major vendors in global hypercholesterolemia drugs market
Exhibit 25: Global lysosomal storage diseases drugs market 2015-2020 ($ billions)
Exhibit 26: Key events in treatment of lysosomal storage diseases
Exhibit 27: Products offered by major vendors in global lysosomal storage disorders drugs market
Exhibit 28: Global anti-obesity drugs market 2015-2020 ($ millions)
Exhibit 29: Products offered by major vendors in global anti-obesity drugs market
Exhibit 30: Global metabolic disorders therapeutics market by geography 2015-2020
Exhibit 31: Global metabolic disorder therapeutics market by geography 2015 and 2020
Exhibit 32: Global metabolic disorder therapeutics market by geography 2015-2020 ($ billions)
Exhibit 33: Global share of metabolic disorder therapeutics market by geography 2015
Exhibit 34: Global share of various metabolic disorder therapeutics market by geography based on disease type 2015
Exhibit 35: Global metabolic disorders therapeutics market by region: Market growth lifecycle analysis 2015
Exhibit 36: Metabolic disorder therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 37: Prevalence of obesity in various countries in Europe 2025
Exhibit 38: Metabolic disorders therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 39: Metabolic disorder therapeutics market in APAC 2015-2020 ($ billions)
Exhibit 40: Prevalence of diabetes in selected countries in APAC 2007 and 2025
Exhibit 41: Few metabolic disorder drugs with patient assistance programs
Exhibit 42: Impact of drivers
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Oral insulin pipeline portfolio
Exhibit 45: Some investigational molecules for metabolic disorders and their mechanisms
Exhibit 46: Key vendors ranking 2015
Exhibit 47: Geographical presence of key vendors
Exhibit 48: Competitive scenario of global metabolic disorders therapeutics market vendors 2015-2020
Exhibit 49: Novo Nordisk: Profile
Exhibit 50: Novo Nordisk: Strength analysis
Exhibit 51: Novo Nordisk: Growth strategy matrix
Exhibit 52: Novo Nordisk: Growth opportunity assessment
Exhibit 53: Novo Nordisk: Business segmentation by revenue 2015
Exhibit 54: Novo Nordisk: Key products in diabetes and obesity care
Exhibit 55: Novo Nordisk: YoY growth and revenue generated from net product sales of human insulins 2012-2015 ($ billions)
Exhibit 56: Novo Nordisk: YoY growth and revenue generated from net product sales of Levemir 2012-2015 ($ billions)
Exhibit 57: Novo Nordisk: YoY growth and revenue of NovoRapid/ NovoLog 2012-2015 ($ billions)
Exhibit 58: Novo Nordisk: YoY growth and revenue of NovoMix/NovoLog Mix 2012-2015 ($ billions)
Exhibit 59: Novo Nordisk: Revenue generated from net product sales of new-generation insulins 2013-2015 ($ millions)
Exhibit 60: Novo Nordisk: YoY growth and revenue of Victoza 2012-2015 ($ billions)
Exhibit 61: Novo Nordisk: YoY growth and revenue of Novonorm, Prandin, and Prandimet 2012-2014 ($ billions)
Exhibit 62: Sanofi: Business segmentation by revenue 2015
Exhibit 63: Sanofi: Profile
Exhibit 64: Sanofi: Strength analysis
Exhibit 65: Sanofi growth strategy matrix
Exhibit 66: Sanofi: Growth opportunity assessment
Exhibit 67: Key product offerings in diabetes market ($ billions)
Exhibit 68: Sanofi: YoY revenue and growth rate of Lantus 2012-2015 ($ billions)
Exhibit 69: Sanofi: YoY revenue and growth rate of Amaryl 2012-2015 ($ billions)
Exhibit 70: Sanofi: YoY revenue and growth rate of Apidra 2012-2015 ($ billions)
Exhibit 71: Sanofi: YoY revenue and growth rate of Insuman 2012-2015 ($ billions)
Exhibit 72: Sanofi: YoY revenue and growth rate of Lyxumia 2013-2015 ($ millions)
Exhibit 73: Sanofi: Revenues of lysosomal storage diseases drugs of Genzyme, 2015
Exhibit 74: Merck: Strength profile
Exhibit 75: Merck: Strength analysis
Exhibit 76: Merck: Growth strategy matrix
Exhibit 77: Merck: Opportunity assessment
Exhibit 78: Top selling diabetes drugs in 2015
Exhibit 79: Merck: Diabetes segmentation by revenue 2015
Exhibit 80: Merck: YoY growth and revenue of Janumet 2012-2015 ($ billions)
Exhibit 81: Merck: YoY growth and revenue of Januvia 2012-2015 ($ billions)
Exhibit 82: Merck: YoY revenue and growth rate of Zetia 2013-2015 ($ billions)
Exhibit 83: Merck: YoY revenue and growth rate of Vytorin 2013-2015 ($ billions)
Exhibit 84: Merck: YoY revenue and growth rate of Zocor 2013-2015 ($ millions)
Exhibit 85: AstraZeneca: Profile
Exhibit 86: AstraZeneca: Strength analysis
Exhibit 87: AstraZeneca: Growth strategy matrix
Exhibit 88: AstraZeneca: Opportunity assessment
Exhibit 89: Top selling diabetes drugs in 2015 ($ billions)
Exhibit 90: AstraZeneca: Byetta YoY growth and revenues 2012-2015 ($ billions)
Exhibit 91: Astrazeneca: Byetta YoY growth rate and revenues in the US ($ billions)
Exhibit 92: AstraZeneca: Bydureon YoY revenues and growth rate 2012-2015 ($ billions)
Exhibit 93: AstraZeneca: Onglyza YoY revenue and growth rate 2012-2015 ($ billions)
Exhibit 94: AstraZeneca: YoY revenue and growth rate of Crestor 2013-2015 ($ billions)
Exhibit 95: AstraZeneca: Geographical segmentation of Crestor 2015 by revenue
Exhibit 96: Eli Lilly: Profile
Exhibit 97: Eli Lilly: Strength analysis
Exhibit 98: Eli Lilly growth strategy matrix
Exhibit 99: Eli Lilly: Opportunity assessment
Exhibit 100: Top selling diabetic drugs 2015 ($ billions)
Exhibit 101: Eli Lilly: YoY revenue and growth rate of Humalog 2012-2015 ($ billions)
Exhibit 102: Eli Lilly: YoY revenue and growth rate of Humulin 2012-2015 ($ billions)
Exhibit 103: Eli Lilly: YoY revenue and growth rate of Tradjenta 2012-2015 ($ billions)
Exhibit 104: Eli Lilly: YoY revenue of Trylicity 2014-2015 ($ millions)
【レポート販売概要】
■ タイトル:代謝疾患治療薬の世界市場:高血圧、肥満、高コレステロール血症、ライソゾーム病■ 英文:Global Metabolic Disorders Therapeutics Market 2016-2020
■ 発行日:2016年9月27日
■ 調査会社:Technavio
■ 商品コード:IRTNTR10218
■ 調査対象地域:グローバル
- シミュレーション及び分析ソフトウェアの世界市場2016-2020About the Simulation and Analysis Software Market Simulation and analysis software is one of the major segments of product life cycle management (PLM) software, and it has a 14% share in the global PLM software market. PLM customers need simulation and analysis tools to achieve long-term benefits of PLM software. Increasing adoption of PLM software enhances the demand for simulation and analysis s …
- 発電業界のM&A及び投資動向(月別):December 2012Power Monthly Deal Analysis - December 2012: M&A and Investment Trends Summary GlobalData's “Power Monthly Deal Analysis - December 2012: M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the power industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture fina …
- 世界の兵士近代化市場(2014-2024):動向、開発、課題Synopsis This report offers readers insights into technological developments in the Soldier Modernization market, as well as detailed analysis of the changing preferences of military forces around the world. It also identifies the current trends in the changing industry structure and the challenges faced by industry participants. Summary Technological Developments in the global Soldier Modernizati …
- 産業用イーサネットの世界市場2016-2020About Ethernet Ethernet is widely used in office and office networks for data transfers. In recent times, it has entered into factory floor to meet the communication needs of industrial applications. The use of standard Ethernet in an industrial environment is called industrial Ethernet. The environment inside industrial plants is harsh with extreme temperature conditions, humidity, and vibration. …
- 髄腔内薬物送達ポンプの世界市場:オピオイド、バクロフェン、ジコノチドAbout the Intrathecal Pumps Market Intrathecal pumps are a category of analgesic infusion pumps that deliver medication into the individual's body for pain management. The intrathecal drug delivery pump is a method of giving medication directly to the spinal cord to stop pain signals from being perceived by the brain. These pumps are small-sized implantable infusion devices. The intrathecal pumps …
- スピルリナ属の世界市場:アルスロスピラプラテンシス、アルスロスピラマキシマSpirulina is a natural algae powder known as cyanobacteria that comprises potent level of proteins, antioxidants, and vitamin B and other nutrients. Spirulina exhibits various benefits such as lowering of LDL and triglyceride levels and anticancer properties. It also reduces blood pressure, is effective against anemia, and improves muscle strength. The global spirulina market generated $348 millio …
- 医療出版の世界市場2019-2023Global Medical Publishing Market: About this market Technavio’s medical publishing market analysis considers sales from journals, print-books, and e-books. Our analysis also considers the sales of medical publishing in APAC, Europe, North America, South America, and MEA. In 2018, the journals segment had a significant market share, and this trend is expected to continue over the forecast period. F …
- 水素燃料電池車の世界市場2017-2021About hydrogen fuel cell vehicle Hydrogen fuel cell vehicles (HFCVs) are a class of electric vehicles that power the drive train of the vehicles through the energy generated from fuel cells. The fuel cell converts chemical energy generated from the positively charged hydrogen ions into electricity. The fuel cell technology has been adopted from the aerospace industry where it was first used to pow …
- ビデオ監視の世界市場:システム種類別(アナログ監視、IP監視、ハイブリッド監視)、コンポーネント別(ハードウェア、ソフトウェア、サービス)、用途別(商業、軍事、防衛、インフラ、住宅、その他)Video surveillance systems can be used for almost any environment. Owing to increase in adoption of advanced surveillance by the government sector, manufacturers have realized the need for optimum IP surveillance systems. There are many advantages that an IP camera CCTV system offers over an analog format. There has been an increase in demand for security applications such as video surveillance to …
- 船舶用接着剤の世界市場予測(~2022年):エポキシ、アクリル、ポリウレタン、金属、複合材、プラスティックThe global marine adhesives market is estimated to be USD 371.9 Million in 2017 and is projected to reach USD 466.2 Million by 2022, at a CAGR of 4.6% from 2017 to 2022. The growing demand for yachts, cruises, recreational boats, and commercial vessels have led to an increase in the demand for marine adhesives from the marine industry. Based on vessel type, the boats segment is projected to witnes …
- 公衆安全およびセキュリティソリューションの世界市場予測:クリティカル通信ネットワーク、バイオメトリクス、認証システム、監視システム、緊急事態・災害管理、サイバーセキュリティThe public safety and security market size is expected to grow from USD 247.53 Billion in 2016 to USD 456.56 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 13.0% during the forecast period. The major growth drivers of the market include rise in criminal activities, natural disaster & cross border terrorism, need for stringent government policies & regulations for public safety, and in …
- クラウドセキュリティのグローバル市場動向(2014-2020)Cloud Security is a strong growing market. This market witnessed the growth, particularly after 2010, when majority of organizations started adopting cloud services for cost cutting, agility and flexibility of IT infrastructure. Also, this era experienced the emergence of cloud specific threats. Hence to balance the migration to cloud services without compromising security led to adoption of cloud …
- BRIC(ブラジル/ロシア/インド/中国)の気道ステント処置動向(~2020)BRIC Airway Stenting Procedures Outlook to 2020 Summary GlobalData’s new report, "BRIC Airway Stenting Procedures Outlook to 2020", provides key market data on the BRIC Airway Stenting Procedures. The report provides procedure volumes within market segments - Malignant Airway Obstruction Stenting Procedures (Silicone Airway Stenting Procedures and Metallic Airway Stenting Procedures (Fully Covered …
- ATMスライドレールの世界市場2016-2020About ATM Slide Rails Slide rails have been an important part of the ATM hardware. They find their application in the pulling out the different mobile components of the ATM hardware components such as cash dispenser unit (CDU), cartridges, error box, deposit box, and also the front panel of the ATM. ATM slide rails come under the business head of the mechanical unit in most of the vendors as these …
- 洗濯物折り畳みロボットの世界市場2018-2022About Laundry Folding Robots Laundry folding robots are designed to fold clothes. The robots are equipped with sensors to identify the cloth and fold accordingly. Technavio’s analysts forecast the Global Laundry Folding Robots Market to grow at a CAGR of 45.01% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the Global Laundry …